Skip to content
healthcare.dev
Get a free key

ATORVALIQ

NDC 46287-030, ATORVALIQ, suspension, from CMP Pharma, Inc..

Product NDC
46287-030
Status
Listed
Labeler
CMP Pharma, Inc.
Dosage form
SUSPENSION
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA213260
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/46287-030 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • ATORVASTATIN CALCIUM TRIHYDRATE20 mg/5mL

Pharmacologic classes

HMG-CoA Reductase Inhibitor [EPC]; Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]

Package NDCNDC-11Package
46287-030-0146287003001150 mL in 1 BOTTLE (46287-030-01)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/41fca2d8-7f3f-45b9-8974-81b89accc211

  • NADAC price for package 46287003001

    GET /v1/drugs/nadac/46287003001

Use it

Look up 46287-030 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/46287-030 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 46287-030. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.